Management of steroid-induced osteoporosis

Chinese Medical Journal

Volumn 113, Issue 8, 2000, Pages 681-685

  Lambrinoudaki, Irene ^b   Kung, Annie W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Osteoporosis; Steroid therapy

Indexed keywords

CALCIUM; ETIDRONIC ACID; STEROID;

BONE ATROPHY; CALCIUM INTAKE; CORTICAL BONE; DRUG INDUCED DISEASE; HUMAN; HYPOGONADISM; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; REVIEW; STEROID THERAPY;

ALGORITHMS; BONE AND BONES; BONE DENSITY; CALCIUM; CROSS-SECTIONAL STUDIES; HUMANS; OSTEOPOROSIS; RISK FACTORS; STEROIDS; VITAMIN D;

EID: 0033867702     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Baltzan MA, Suissa S, Bauer DC, et al. Hip fractures attributable to corticosteroid use. Study of osteoporotic fracture group. Lancet 1999;353:1327.
2. Walsch LJ, Wong CA, Pringle M, et al. Use of oral costricosteroids in the community and the prevention of secondary ostreoporosis: a cross-sectional study. Br Med J 1996;313;344-346.
3. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7:407-413.
4. Reid IR. Glucocorticoid osteoporosis: mechanisms and management. Eur J Endocrinol 1997;137:209-217.
5. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosterid fracture and hip fracture. Ann Rheum Dis 1995;54:49-52.
6. Reid IR, Evans MC, Stapleton J. Lateral spine densitometry is a more sensitive indicator of glucocorticoid -induced bone loss. J Bone Miner Res 1992;7:1221-1225.
7. Eastell R, Reid DM, Compston J. A UK consensus group on management of glucocorticoid induced osteoporosis: an update. J Intern Med 1998;244:271-292.
8. Sambrook PN, Kelly PJ, Fontana D, et al. Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 1994; 4:273-276.
9. Laan RF, van Riel PL, van de Putte LB, et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 1993;119:963-968.
10. Ebeling PR, Erbas B, Hopper JL, et al. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 1998;13:1283-1289.
11. Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105:1722-1727.
12. Woo J, Leung SS, Ho SC, et al. Dietary intake and practices in the Hong Kong Chinese population. J Epidemiol Community Health 1998;52:631-637.
13. Kung AW, Luk KD, Chu LW, et al. Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation. Am J Clin Nutr 1998;68:1291-1297.
14. Lau EMC, Cooper C. The epidemiology of osteoporosis. The oriental perspective in a world context. Clin Orthop 1996;323:65-74.
15. Kung AWC, Tang GWK, Luk KDK, et al. Evaluation of a new calcaneal quantitative ultrasound system and determination cf normative ultrasound values in southern Chinese women. Osteoporos Int 1999;9:312-317.
16. Ho SC. Body measurements, bone mass, and fractures. Does the East differ from the West? Clin Orthop 1996;323:75-80.
17. Li EK, Tam LS, Young RP, et al. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 1998;37: 405-410.
18. Kung AWC, Chan TM, Lau CS, et al. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a comparison between calcitriol and hormonal replacement therapy. Rheumatol (Oxf) (accepted for publication).
19. Tobias IH. Management of steroid-induced osteoporosis: what is the current state of play? Rheumatol (Oxf) 1999;38:198-201.
20. Sambrook P, Birmingham J, Kelly P, et al. Prevention cf corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-1752.
21. Wang WQ, Ip MS, Tsang KW, et al. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months. J Allergy Clin Immunol 1998;101:445-450.
22. 3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treament: a double blind controlled study. Clin Endocrinol (Oxf) 1983;19:265-273.
23. Reginster JY, Kuntz D, Verdickt W, et al. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 1999;9:75-81.
24. Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996;125:961-968.
25. Adachi JD, Bensen WB, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3-year follow-up. J Rheumatol 1996;23:995-1000.
26. Dykman TR, Haralson KM, Gluck OS, et al. Effect of oral 1, 25-dihydroxyvitamin D and calcium in patients with rheumatic diseases. Arthritis Rheum 1984;12:1336-1343.
27. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 1998;27:465-483.
28. Hall GM, Daniels M, Doyle DV, et al. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994;37:1499-1505.
29. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesteron replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-1069.
30. Chavassieux PM, Arlot ME, Reda C, et al. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100:1475-1480.
31. Homik JE, Cranney A, Shea B, et al. A metaanalysis on the use of bisphoshorates in corticosteroid induced osteoporosis. J Rheumatol 1999;26:1148-1157.
32. Adachi JD, Bensen WG, Bell MJ, et al. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Br J Rheumatol 1997;36:255-259.
33. Luengo M, Pons F, Martinez de Osaba MJ, et al. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow-up study. Thorax 1994;49:1099-1102.